Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simona Rolla

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Frontiers in Immunology|March 17, 2022
Long-Term Effects of Alemtuzumab on CD4+ Lymphocytes in Multiple Sclerosis Patients: A 72-Month Follow-UpSimona Rolla, Stefania Federica De Mercanti, Valentina Bardina, et al.
The Journal of Clinical Investigation|March 3, 2004
Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesionsElena Quaglino, Simona Rolla, Manuela Iezzi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 6, 2012
Th17 cells in multiple sclerosis express higher levels of JAK2, which increases their surface expression of IFN-γR2Laura Conti, Raffaele De Palma, Simona Rolla, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 27, 2014
Chimeric rat/human HER2 efficiently circumvents HER2 tolerance in cancer patientsSergio Occhipinti, Laura Sponton, Simona Rolla, et al.
Clinical Science (London, England : 1979)|November 22, 2015
Intra-tumoral IFN-γ-producing Th22 cells correlate with TNM staging and the worst outcomes in pancreatic cancerElena Niccolai, Antonio Taddei, Federica Ricci, et al.
Frontiers in Immunology|January 24, 2019
Pregnancy Epigenetic Signature in T Helper 17 and T Regulatory Cells in Multiple SclerosisAndrea Iannello, Simona Rolla, Alessandro Maglione, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Frontiers in Immunology|March 17, 2022
Long-Term Effects of Alemtuzumab on CD4+ Lymphocytes in Multiple Sclerosis Patients: A 72-Month Follow-UpSimona Rolla, Stefania Federica De Mercanti, Valentina Bardina, et al.
The Journal of Clinical Investigation|March 3, 2004
Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesionsElena Quaglino, Simona Rolla, Manuela Iezzi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 6, 2012
Th17 cells in multiple sclerosis express higher levels of JAK2, which increases their surface expression of IFN-γR2Laura Conti, Raffaele De Palma, Simona Rolla, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 27, 2014
Chimeric rat/human HER2 efficiently circumvents HER2 tolerance in cancer patientsSergio Occhipinti, Laura Sponton, Simona Rolla, et al.
Clinical Science (London, England : 1979)|November 22, 2015
Intra-tumoral IFN-γ-producing Th22 cells correlate with TNM staging and the worst outcomes in pancreatic cancerElena Niccolai, Antonio Taddei, Federica Ricci, et al.
Frontiers in Immunology|January 24, 2019
Pregnancy Epigenetic Signature in T Helper 17 and T Regulatory Cells in Multiple SclerosisAndrea Iannello, Simona Rolla, Alessandro Maglione, et al.
Pageof 4